Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TruGolf Announces Reverse Stock Split
-
OTSAW Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
BOXX Redefines Creative Power with Launch of Creativ PCs™: The Industry's Most Performant Creator PC
-
OHA is Administrative Agent and Lead Left Arranger of Private Debt Financing Supporting Montagu’s Acquisition of Tyber Medical
-
PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and N
-
Synergy CHC (NASDAQ: SNYR) Expands FOCUSfactor® to UAE & Turkey — Ignites Global Growth and New Revenue Streams
-
Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year
-
Future Today Brings YouTube Creators to Streaming Audiences, Growing Both Creator Brands and Its Expansive OTT Portfolio
-
Pessimism About Future Household Finances Rises, Yet Majority of U.S. Consumers Remain Optimistic
-
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
-
Alpha Modus Expands CashX Rollout via Strategic U.S. Reseller Agreement with Genmega
-
Driving Innovation in CTE: Upper Bucks County Technical School and Patrick Chrinko Named zSpace School and Educator of Distinction
-
Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
-
Change in Huhtamaki’s Global Executive Team
-
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
-
Forbes Recognizes Beacon College on Accessibility 100 List
-
Statkraft strengthens core activities and competitiveness following strategic review
-
Moleculin Participates in Virtual Investor “What This Means” Segment
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
XRP News: Martini Market, The First Decentralized Prediction Markets On XRP Announces Its MRT Token Presale
-
Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
-
Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early Fruit
-
Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade to BB- from B+
-
Bowman Leads $24 Million Water System Upgrades in Del Norte, CO
-
Zefiro Subsidiary Awarded USD $19.6 Million Plugging & Abandonment Management Contract from the Ohio Department of Natural Resources
-
IT Teams are Losing Visibility as Tech Cost Pressures Mount, According to Flexera 2025 State of ITAM Report
-
Novacium Launches Industrial Production of High-Performance Batteries Incorporating Its Silicon-Based Anode Material
-
Purpose Investments Launches Purpose XRP ETF, Adding to Its Diverse and Growing Suite of Digital Asset ETFs
-
Valour Launches Four New ETPs on Spotlight Stock Market: Mantra (OM), Tron (TRX), Stellar (XLM), and Tether Gold (XAUT)
-
Near Surface Infill-Drilling to Assess Open Pit Production Intersects 45.38 g/t Au over 3.13 m core length, including 141.00 g/t Au over 0.88 m
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade to BB- from B+
-
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
-
Zefiro Subsidiary Awarded USD $19.6 Million Plugging & Abandonment Management Contract from the Ohio Department of Natural Resources
-
Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X
-
XOMA Royalty Declares Quarterly Preferred Stock Dividends
-
Dynacor Group Announces Election of Directors
-
F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim
-
Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
-
Form 8.3 - [Alpha Group International PLC]
-
Grant of warrants
-
SalMar - Minutes from annual general meeting
-
Microchip Enhances Digital Signal Controller Lineup with Industry-Leading PWM Resolution and ADC Speed
-
SunRocket Capital Provides Financing for Golden Gate Capital's C&I Rooftop Solar Installation in New Jersey
-
SunRocket Capital Provides Financing for Golden Gate Capital's C&I Rooftop Solar Installation in New Jersey
-
Net Asset Value(s)
-
NexGold VP Sustainability Receives Prestigious Mining Society of Nova Scotia Medal
-
Troilus Agrees to Commercial Offtake Terms with Aurubis for Its Copper-Gold Concentrate
-
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China
-
Central Ossington Opens July 3 – Toronto’s Newest Spot for Food, Cocktails, and Culture
